119 related articles for article (PubMed ID: 2481766)
1. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
Costard-Jaeckle A; Liem LB; Franz MR
J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
[TBL] [Abstract][Full Text] [Related]
2. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
3. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
Franz MR; Costard A
Circulation; 1988 May; 77(5):1177-84. PubMed ID: 3359594
[TBL] [Abstract][Full Text] [Related]
4. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Duff HJ; Rahmberg M; Sheldon RS
J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
[TBL] [Abstract][Full Text] [Related]
5. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
Burke GH; Loukides JE; Berman ND
J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
Duff HJ; Cannon NJ; Sheldon RS
Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
[TBL] [Abstract][Full Text] [Related]
7. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
[TBL] [Abstract][Full Text] [Related]
8. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Roden DM; Iansmith DH; Woosley RL
J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
[TBL] [Abstract][Full Text] [Related]
9. Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.
Uematsu T; Sato R; Vozeh S; Follath F; Nakashima M
Arch Int Pharmacodyn Ther; 1989; 297():29-38. PubMed ID: 2730239
[TBL] [Abstract][Full Text] [Related]
10. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
11. Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.
Nakaya Y; Elharrar V; Surawicz B
Cardiovasc Drugs Ther; 1987 Aug; 1(2):141-53. PubMed ID: 3154317
[TBL] [Abstract][Full Text] [Related]
12. Electropharmacologic synergism with mexiletine and quinidine.
Duff HJ; Kolodgie FD; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
[TBL] [Abstract][Full Text] [Related]
13. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
Bajaj AK; Kopelman HA; Wikswo JP; Cassidy F; Woosley RL; Roden DM
Circulation; 1987 May; 75(5):1065-73. PubMed ID: 2436827
[TBL] [Abstract][Full Text] [Related]
14. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
Duff HJ; Gault NJ
J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
[TBL] [Abstract][Full Text] [Related]
15. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
16. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
Rosenheck S; Schmaltz S; Kadish AH; Summitt J; Morady F
Am Heart J; 1991 Feb; 121(2 Pt 1):512-7. PubMed ID: 1990756
[TBL] [Abstract][Full Text] [Related]
17. [Impact of late sodium current inhibition on cardiac electrophysiology parameters and ventricular arrhythmias in isolated Langendorff perfused rabbit hearts with short QT interval].
Huang YW; Chen Y; Wang CY; Wu L
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Nov; 50(11):1087-1093. PubMed ID: 36418277
[No Abstract] [Full Text] [Related]
18. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
Sager PT; Behboodikhah M
J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
[TBL] [Abstract][Full Text] [Related]
19. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
Burke GH; Loukides JE; Berman ND
J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
[TBL] [Abstract][Full Text] [Related]
20. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Duff HJ
J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
